208 related articles for article (PubMed ID: 1146926)
21. [Histologic and radioautographic studies of the human endometrium under sequential oral contraceptive conditions (author's transl)].
Kaltenbach FJ; Fettig O; Welter J
Arch Gynakol; 1973; 215(3):325-42. PubMed ID: 4800864
[TBL] [Abstract][Full Text] [Related]
22. Carbohydrate metabolism during treatment with estrogen, progestogen, and low-dose oral contraceptives.
Spellacy WN
Am J Obstet Gynecol; 1982 Mar; 142(6 Pt 2):732-4. PubMed ID: 7039318
[TBL] [Abstract][Full Text] [Related]
23. Endometrial changes induced by the administration of an oral contraceptive, norethindrone (S-3800B).
Utsumi K; Kuribayashi N; Kumakiri S
Acta Pathol Jpn; 1966 May; 16(2):141-50. PubMed ID: 6012525
[TBL] [Abstract][Full Text] [Related]
24. Effects of contraceptive agents on the biochemical and protein composition of human endometrium.
Umapathysivam K; Jones WR
Contraception; 1980 Oct; 22(4):425-40. PubMed ID: 6160951
[TBL] [Abstract][Full Text] [Related]
25. [Femigen forte and mite preparations in contraception and gynecologival disorders].
Sternadel Z; Pietrusiewicz W; Wasilewska B
Ginekol Pol; 1970 Nov; 41(11):1227-36. PubMed ID: 4098877
[TBL] [Abstract][Full Text] [Related]
26. Effects of cyproterone acetate and ethinylestradiol on endometrial histology.
Klebe U; Moltz L; Pickartz H
Arch Gynecol; 1983; 234(2):113-20. PubMed ID: 6667041
[TBL] [Abstract][Full Text] [Related]
27. Pill-a-month as an oral contraceptive.
Hefnawi F; Hassanein M; Younis N
Egypt Popul Fam Plann Rev; 1972 Jun; 5(1):1-17. PubMed ID: 12256024
[TBL] [Abstract][Full Text] [Related]
28. Effects of contraceptive pills and intrauterine devices on urinary bladder.
Zahran MM; Osman MI; Kamel M; Fayad M; Mooro H; Youssef AF
Urology; 1976 Dec; 8(6):567-74. PubMed ID: 793141
[TBL] [Abstract][Full Text] [Related]
29. Effect of oral alanine loads on plasma amino acids in oral contraceptive users and control women.
Potera C; Rose DP
Am J Clin Nutr; 1978 May; 31(5):794-8. PubMed ID: 645627
[TBL] [Abstract][Full Text] [Related]
30. The effect of contraceptive steroids on hypothalamic-pituitary function.
Mishell DR; Kletzky OA; Brenner PF; Roy S; Nicoloff J
Am J Obstet Gynecol; 1977 May; 128(1):60-74. PubMed ID: 403765
[TBL] [Abstract][Full Text] [Related]
31. Plasma levels of adrenocorticotropin and cortisol in women receiving oral contraceptive steroid treatment.
Carr BR; Parker CR; Madden JD; MacDonald PC; Porter JC
J Clin Endocrinol Metab; 1979 Sep; 49(3):346-9. PubMed ID: 224073
[TBL] [Abstract][Full Text] [Related]
32. Effect of oral contraceptives on nutrients. III. Vitamins B6, B12, and folic acid.
Prasad AS; Lei KY; Moghissi KS; Stryker JC; Oberleas D
Am J Obstet Gynecol; 1976 Aug; 125(8):1063-9. PubMed ID: 952302
[TBL] [Abstract][Full Text] [Related]
33. A comparative metabolic study of two low-estrogen-dose oral contraceptives containing desogestrel or gestodene progestins.
Crook D; Godsland IF; Worthington M; Felton CV; Proudler AJ; Stevenson JC
Am J Obstet Gynecol; 1993 Nov; 169(5):1183-9. PubMed ID: 8238183
[TBL] [Abstract][Full Text] [Related]
34. Oestrogen treatment for increased bleeding in Norplant users: preliminary results.
Witjaksono J; Lau TM; Affandi B; Rogers PA
Hum Reprod; 1996 Oct; 11 Suppl 2():109-14. PubMed ID: 8982752
[TBL] [Abstract][Full Text] [Related]
35. Endometrial effects of a 91-day extended-regimen oral contraceptive with low-dose estrogen in place of placebo.
Anderson FD; Feldman R; Reape KZ
Contraception; 2008 Feb; 77(2):91-6. PubMed ID: 18226671
[TBL] [Abstract][Full Text] [Related]
36. Effect of estrogen/progestin potency on lipid/lipoprotein cholesterol.
Wahl P; Walden C; Knopp R; Hoover J; Wallace R; Heiss G; Rifkind B
N Engl J Med; 1983 Apr; 308(15):862-7. PubMed ID: 6572785
[TBL] [Abstract][Full Text] [Related]
37. Insulin sensitivity is decreased in normal women by doses of ethinyl estradiol used in oral contraceptives.
Kojima T; Lindheim SR; Duffy DM; Vijod MA; Stanczyk FZ; Lobo RA
Am J Obstet Gynecol; 1993 Dec; 169(6):1540-4. PubMed ID: 8267059
[TBL] [Abstract][Full Text] [Related]
38. Histopathological and histochemical changes in the cervix uteri under contraceptive pills.
El Hakim SM; Abdin FH; Kandil O
Egypt Popul Fam Plann Rev; 1976 Dec; 10(2):20-33. PubMed ID: 12308408
[TBL] [Abstract][Full Text] [Related]
39. Chromatographic patterns of urinary ethynyl estrogen metabolites in various populations.
Williams MC; Goldzieher JW
Steroids; 1980 Sep; 36(3):255-82. PubMed ID: 7434400
[TBL] [Abstract][Full Text] [Related]
40. Some aspects of studies with oral contraceptives in Indian women.
Shah PN
J Obstet Gynaecol India; 1966 Aug; 16(4):409-14. PubMed ID: 12262163
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
